After Tense Fights, An FDA Panel Said Pfizer Boosters Should Go To Older Adults And Others At High Risk

ad300
Advertisement

The advisory panel of outside health experts recommended that a third dose of the Pfizer vaccine be authorized for people over 65 and those at high risk, rejecting the benefit for the general population.


View Entire Post ›

Share This

Related Posts:

0 comments: